Evidence-Based De-Escalation in Axillary Management-Is Less Really More?
- PMID: 37285138
- PMCID: PMC10527598
- DOI: 10.1001/jamasurg.2023.1783
Evidence-Based De-Escalation in Axillary Management-Is Less Really More?
Comment on
-
Safety of Targeted Axillary Dissection After Neoadjuvant Therapy in Patients With Node-Positive Breast Cancer.JAMA Surg. 2023 Aug 1;158(8):807-815. doi: 10.1001/jamasurg.2023.1772. JAMA Surg. 2023. PMID: 37285140 Free PMC article.
References
-
- Boughey JC, Ballman KV, Le-Petross HT, et al. Identification and Resection of Clipped Node Decreases the False-negative Rate of Sentinel Lymph Node Surgery in Patients Presenting With Node-positive Breast Cancer (T0-T4, N1-N2) Who Receive Neoadjuvant Chemotherapy: Results From ACOSOG Z1071 (Alliance). Ann Surg Apr 2016;263(4):802–7. doi:10.1097/sla.0000000000001375 - DOI - PMC - PubMed
-
- Caudle AS, Yang WT, Krishnamurthy S, et al. Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection. J Clin Oncol Apr 1 2016;34(10):1072–8. doi:10.1200/jco.2015.64.0094 - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical